InsidersTradesSigma
Follow the 株式会社ツムラ share price and the full directors' dealings record of the company, a listed issuer based in Japan. Shares are listed on JP JP, under the supervision of EDINET (Japan FSA). Market capitalisation: €36,492bn. The latest transaction was reported on 20 November 2025 (Holding update). Among the most active insiders: Invesco Asset Management (Japan) Limited. The full history is free.
Analysts rate 株式会社ツムラ Buy (bullish), based on 11 analysts. Average price target: JP¥3,312.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
16 of 16 declarations
Tsukuba Pharmaceutical Co., Ltd. is a Japanese company engaged in the manufacturing of pharmaceutical and healthcare products. It is listed on the Tokyo Stock Exchange under the symbol XTKS.